Qilu Pharmaceuticals, Super Large Variety Submit Consistency Evaluation
-
Last Update: 2018-11-27
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
original title: Qilu Pharmaceuticals, Super Big Variety SubmitSco EvaluationInjection with pemequer sodium, the domestic market is currently mainly Lilly's original research bitai, Howson Pharmaceutical Sule, Qilu Pharmaceutical Saizhen2016 Pemescmarket Market, with a purchase value of $2.6 billion based on the Metere TERMINALHowson Pharmaceuticals ranked first in the Permexemarket generic market with a market share of nearly 40%, followed by Qilu Pharmaceuticals with a market share of 33% in 2016 and Lilly Pharmaceuticals with 13% of the market share2017 China's public medical institutions terminal about 4.8 billion, injection with the market of permiced sodium basically achieved imitation substitution, Jiangsu Howsen Pharmaceuticals and Qilu Pharmaceuticals together accounted for more than 70% of the market sharereference:CDE/NMPA/FDA/EMA; Pharmaceutical Meltdata, Pharnex Datamonitor; Pharmaceutical Syntagdo-related companies publicly disclosed, etc
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
